NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

Search

Roche Holding AG

Geschlossen

BrancheGesundheitswesen

277.4 -0.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

276.4

Max

280

Schlüsselkennzahlen

By Trading Economics

Einkommen

-4.2B

2B

Verkäufe

-109M

31B

KGV

Branchendurchschnitt

26.874

50.291

Dividendenrendite

3.5

Gewinnspanne

6.588

Angestellte

103,249

EBITDA

-4.6B

6B

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

3.50%

2.40%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-11B

208B

Vorheriger Eröffnungskurs

277.69

Vorheriger Schlusskurs

277.4

Nachrichtenstimmung

By Acuity

22%

78%

45 / 380 Ranking in Healthcare

Roche Holding AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Juni 2025, 08:25 UTC

Akquisitionen, Fusionen, Übernahmen

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12. Mai 2025, 02:16 UTC

Wichtige Markttreiber

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24. Apr. 2025, 07:30 UTC

Ergebnisse

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24. Apr. 2025, 05:31 UTC

Ergebnisse

Roche Sales Rise Boosted By Key Drugs

9. Apr. 2025, 09:39 UTC

Wichtige Markttreiber

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12. März 2025, 09:23 UTC

Wichtige Markttreiber

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30. Jan. 2025, 09:36 UTC

Ergebnisse

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30. Jan. 2025, 06:32 UTC

Ergebnisse

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

16. Juni 2025, 08:55 UTC

Heiße Aktien

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3. Juni 2025, 07:51 UTC

Market Talk

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21. Mai 2025, 07:20 UTC

Market Talk

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2. Mai 2025, 06:25 UTC

Market Talk
Ergebnisse

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24. Apr. 2025, 09:39 UTC

Market Talk
Ergebnisse

Roche's Pipeline in Focus After Solid Results -- Market Talk

24. Apr. 2025, 09:24 UTC

Market Talk
Ergebnisse

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24. Apr. 2025, 09:18 UTC

Market Talk
Ergebnisse

Roche's Results Are Solid -- Market Talk

24. Apr. 2025, 05:16 UTC

Top News

Roche Sales Rise, Boosted By Key Drugs

22. Apr. 2025, 10:51 UTC

Top News

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15. Apr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9. Apr. 2025, 10:03 UTC

Market Talk
Ergebnisse

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9. Apr. 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3. Apr. 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3. Apr. 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31. März 2025, 09:31 UTC

Heiße Aktien

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13. März 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12. März 2025, 16:34 UTC

Top News

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12. März 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12. März 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13. Feb. 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30. Jan. 2025, 07:56 UTC

Market Talk
Ergebnisse

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30. Jan. 2025, 06:04 UTC

Ergebnisse

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

Peer-Vergleich

Kursveränderung

Roche Holding AG Prognose

Stimmung

By Acuity

45 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.